|
CINP model | CB receptor agonist | Effects | Effects of CB receptor antagonists on the activity of the compound | Reference |
Chemotherapy drug | Animal |
|
Nonselective CB1/CB2 receptor agonists |
Cisplatin | Male C3H/HeN mice | 2-AG | Suppressed established mechanical hyperalgesia | CB1 receptor antagonist AM281 antagonised | [26] |
CB2 receptor antagonist AM630 had no effect |
Cisplatin | Male C3H/HeN mice | AEA | Suppressed established mechanical hyperalgesia | CB1 antagonist AM281 antagonised | [25] |
CB2 antagonist AM630 had no effects |
Paclitaxel | CD1 and C57BL/6J mice | THC | Suppressed established mechanical and cold allodynia | No antagonists were used | [30] |
Cisplatin | Male C57BL/6 mice | THC | Suppressed established mechanical allodynia | No antagonists were used | [31] |
Did not prevent the development of mechanical allodynia |
Paclitaxel | CD1 and C57BL/6J mice | CP55,940 | Suppressed established mechanical and cold allodynia | CB2 antagonist AM630 antagonised | [32] |
Paclitaxel | Male Wistar rats | WIN | Suppressed established thermal hyperalgesia and mechanical allodynia | CB1 antagonist SR141716A antagonised | [33] |
Vincristine | Male SD rats | WIN | Suppressed established mechanical allodynia | Both CB1 antagonist SR141716 and CB2 antagonist SR144528 antagonised | [34] |
Cisplatin | Male Wistar rats | WIN | Prevented the development of mechanical allodynia | No antagonists were used | [35] |
Paclitaxel | Male Wistar rats | WIN | Prevented the development of thermal hyperalgesia and mechanical allodynia | No antagonists were used | [36] |
Cisplatin | Male Wistar rats | WIN | Prevented the development of mechanical allodynia | No antagonists were used | [37] |
Cisplatin | Male Wistar rats | WIN | Suppressed established mechanical allodynia | Both CB1 antagonist AM251 and CB2 antagonist SR144528 antagonised | [38] |
Paclitaxel | Male SD rats | WIN | Prevented the development of mechanical and cold allodynia | CB1 receptor antagonist AM251 antagonised mechanical allodynia but not cold allodynia | [39] |
CB2 receptor antagonist AM630 did not reliably antagonise both mechanical and cold allodynia |
CB1 receptor-selective agonists |
Cisplatin | Male Wistar rats | ACEA | Suppressed established mechanical allodynia | CB1 antagonist AM251 antagonised | [38] |
Paclitaxel | Male CD1 and C57BL/6J mice | GAT211 (CB1 PAM) | Suppressed mechanical and cold allodynia | CB1 receptor antagonist AM251 antagonised | [29] |
CB2 receptor antagonist AM630 had no effect |
CB2 receptor-selective agonists |
Vincristine | Male SD rats | AM1241 | Suppressed established mechanical allodynia | CB1 antagonist SR141716 had no effect | [34] |
CB2 antagonist SR144528 antagonised |
Paclitaxel | Male SD rats | AM1241 and AM1714 | Suppressed established mechanical allodynia | CB1 antagonist SR141716 had no effect | [40] |
CB2 antagonist SR144528 antagonised |
Cisplatin and paclitaxel | Male SD rats | AM1710 | Suppressed established mechanical and cold allodynia | CB1 antagonist AM251 had no effect | [41] |
CB2 antagonist AM630 antagonised |
Paclitaxel | Male SD rats | AM1710 | Prevented the development of mechanical and cold allodynia | CB1 receptor antagonist AM251 had no effect | [39] |
CB2 receptor antagonist AM630 antagonised |
Paclitaxel | CD1 and C57BL/6J mice | AM1710 | Suppressed established mechanical and cold allodynia | CB2 antagonist AM630 antagonised | [30] |
Paclitaxel | Male SD rats | MDA7 | Suppressed established mechanical allodynia | No antagonists were used | [42] |
Paclitaxel | Male SD rats and mice (strain not specified) | MDA7 | Suppressed established mechanical allodynia | CB2 antagonist AM630 antagonised | [43] |
Paclitaxel | Male SD rats | MDA7 | Prevented the development of mechanical allodynia | No antagonists were used in paclitaxel-induced mechanical allodynia | [44] |
Paclitaxel | Male SD rats and mice (strain not specified) | MDA19 | Suppressed established mechanical allodynia | No antagonists were used | [45] |
Paclitaxel | Male C57BL/6J mice | LY2828360 | Suppressed established mechanical and cold allodynia | No antagonists were used | [46] |
Cisplatin | Male Wistar rats | JWH133 | Suppressed established mechanical allodynia | CB2 antagonist SR144528 antagonised | [38] |
Paclitaxel | Male Swiss mice | BCP | Prevented the development of mechanical allodynia | CB1 receptor antagonist AM251 had no effect | [47] |
Suppressed established mechanical allodynia | CB2 receptor antagonist AM630 antagonised |
|